Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on June 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

PHARM MANUF/DISTR DIV - FSA

Closed
SPE2D2-26-R-0007Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The solicitation SPE2D2-26-R-0007 seeks Fingolimod 0.5 MG capsules in 30-count bottles under a firm-fixed-price requirements contract with a one-year base period and four optional one-year extension periods, allowing for a maximum five-year term. The procurement is administered by the Defense Logistics Agency Troop Support in Philadelphia, Pennsylvania, and is intended to establish a supply source for the Prime Vendor Program, requiring the contractor to enter into business-to-business agreements with both DLA and VA prime vendors. The product must adhere to stringent packaging and labeling specifications, including child-proof closures, cylindrical 100cc non-glass bottles with a minimum 5.75-inch circumference, compatibility with automated dispensing systems like Baxter ATC Canisters and OptiFill, and GS1-128 or HIBC-compliant barcoding with a 0.5-inch safety margin for expiration and lot data. All packages must include NDC, lot, and expiration information, and the contractor must provide FDA approval documentation via NDA or ANDA, declare whether they are the manufacturer or distributor, and supply the manufacturing facility’s details if acting as a distributor. Proposals must be submitted electronically via DIBBS by July 9, 2026, at 3:00 PM EST, and must include two volumes: a non-price section with completed SF 1449, country-of-origin trade agreements charts, FDA warning letter disclosures, and representations, and a price section with unit pricing per bottle for the base and all four option years. The evaluation follows a Lowest Price Technically Acceptable model, where technical compliance and past performance are pass/fail criteria; failure in either results in overall rejection regardless of price. The awarded contract will also include a 0.5 percent cost recovery fee payable quarterly to the U.S. Treasury, with sales reports containing NDC, quantity, unit price, extended price, invoice, ship date, prime vendor, distribution center, and customer information. Contractors must maintain current SAM registration with a Unique Entity Identifier and EFT payment setup, and large businesses must submit a subcontracting plan. Special requirements include compliance with DFARS prohibitions on covered telecommunications equipment, prohibitions on internal confidentiality agreements, contractor ethics codes, and representations related to foreign ownership, Buy American provisions, and trade agreements. Contract administration occurs through the same office responsible for the solicitation, with no government involvement in prime vendor financial disputes and chargebacks managed directly between

General Info

DLA seeks competitive contract for Fingolimod capsules supply, one-year base plus four options.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN FSGBView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

USA

Set-Aside

NONE

Documents

(7)

Amendment 0002 to Solicitation SPE2D226R0007

PDFamendment

Amendment 0002 to Solicitation SPE2D226R0007

PDFamendment

Amendment 0001 to Solicitation SPE2D226R0007

PDFamendment

Solicitation SPE2D2-26-R-0007 for Fingolimod

PDFrfp

Amendment 0001 to Solicitation SPE2D226R0007

PDFamendment

Solicitation SPE2D2-26-R-0007 for Commercial Items

PDFrfp

Solicitation SPE2D2-26-R-0007 for Commercial Items

PDFrfp

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

4 updates
PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Amendment 1

Contract was updated

Amendment 2

Contract was updated

Amendment 3

Contract was updated

Amendment 4

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN FSGB
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN FSGB
View Agency Profile
Office AddressUSA
Contacts
HENRY SHELLY

Full Description

Show more
PHARM MANUF/DISTR DIV - FSA NSN/Part Number: 3RFQ3SEESOW

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN FSGB

Same awarding agency

NAICS: 325412
DIBBS
PHARM MANUF/DISTR DIV - FSA
Solicitation # SPE2D2-26-R-0012
Solicitation SPE2D2-26-R-0012 is a requirements contract issued by the Defense Logistics Agency (DLA) Troop Support to establish a national supply source for Febuxostat 40mg and 80mg tablets. The objective is to provide these pharmaceutical products to Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the Pharmaceutical Prime Vendor (PPV) program. The contract consists of a one-year base period with four subsequent one-year options, for a maximum term of five years. Award is based on a lowest price technically acceptable (LPTA) basis, requiring offerors to be technically acceptable and provide the lowest evaluated aggregate price. The awarded contractor must enter into business-to-business agreements with DLA and VA PPV contractors, as payments and invoicing will be handled through these prime vendors rather than directly by the government. Key operational requirements include strict adherence to FDA current Good Manufacturing Practices (cGMP), the provision of FDA-approved products with a Therapeutic Equivalence Code of A, and compliance with the Drug Supply Chain Security Act. Packaging must feature child-proof closures and specific bottle dimensions to ensure compatibility with automated dispensing units. Labeling must meet GS1-128 or HIBCC standards with a quality grade of C or better, including lot numbers and expiration dates. The contractor is also required to register product information with RXNorm, First Data Bank, and Medi-Span.
Pharmaceutical Preparation Manufacturing

POSTED

17 days ago

DEADLINE

in 13 days
View Details
NAICS: 424210
DIBBS
PHARM MANUF/DISTR DIV - FSA
Solicitation # SPE2D2-26-R-0015
Solicitation SPE2D2-26-R-0015 is a request for proposal issued by the Defense Logistics Agency (DLA) Troop Support to establish a national supply source for Progesterone 100MG and 200MG capsules. The contract is designed to support the Pharmaceutical Prime Vendor (PPV) program, serving the Department of Defense, Department of Veterans Affairs, Indian Health Service, and the Bureau of Prisons. The award will be for a one-year base period with four optional extension years, for a maximum term of five years. The procurement is unrestricted but includes considerations for small businesses, HUBZone, service-disabled veteran-owned, and women-owned small businesses. The selected contractor must enter into business-to-business agreements with DLA and VA PPV contractors, as payments will be processed through these prime vendors rather than directly from the government. Key performance requirements include a contract performance date 45 days after award and a price effective date within 60 days of award. Deliveries must be completed within 15 calendar days of order receipt. The contractor is required to adhere to strict FDA current Good Manufacturing Practices (cGMP) and specific packaging and labeling standards, including the use of child-proof closures and GS1-128 or HIBCC compliant bar coding at the unit-of-use level. Evaluation is based on a pass/fail technical and past performance assessment, with the final award granted to the lowest evaluated aggregate price. The contractor must also comply with DFARS 252.204-7018 regarding the prohibition of covered defense telecommunications equipment or services, requiring the disclosure of any such use and the implementation of mitigation actions to prevent future occurrences.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 2 months ago

DEADLINE

in 7 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS